CCME Global Ltd
Incorporated in 1992, Genesis IBRC India Ltd (Formerly SSK Lifestyles Limited) is in the business of Biotechnology.
- Market Cap ₹ 557 Cr.
- Current Price ₹ 123
- High / Low ₹ 185 / 20.2
- Stock P/E
- Book Value ₹ 7.39
- Dividend Yield 0.00 %
- ROCE %
- ROE -0.31 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 62.8% over last quarter.
Cons
- Stock is trading at 16.6 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | |
|---|---|
| 4.33 | |
| 4.15 | |
| Operating Profit | 0.18 |
| OPM % | 4.16% |
| 0.01 | |
| Interest | 0.03 |
| Depreciation | 0.09 |
| Profit before tax | 0.07 |
| Tax % | 128.57% |
| -0.03 | |
| EPS in Rs | -0.02 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 126% |
| 1 Year: | 539% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | |
|---|---|
| Equity Capital | 13.00 |
| Reserves | -3.39 |
| 1.48 | |
| 1.21 | |
| Total Liabilities | 12.30 |
| 2.07 | |
| CWIP | 1.30 |
| Investments | 0.00 |
| 8.93 | |
| Total Assets | 12.30 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | |
|---|---|
| 1.68 | |
| -4.66 | |
| 3.00 | |
| Net Cash Flow | 0.02 |
| Free Cash Flow | 1.68 |
| CFO/OP | 933% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | |
|---|---|
| Debtor Days | 119.70 |
| Inventory Days | 68.92 |
| Days Payable | 17.87 |
| Cash Conversion Cycle | 170.75 |
| Working Capital Days | 399.56 |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Benefit Expenses INR ・Standalone data |
|
||||||||||
| Purchase of Traded Goods INR ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Intimation About Receipt Of Listing Approval For 32250000 Equity Shares Allotted On March 26, 2026
30 Apr - BSE approved listing of 3,22,50,000 equity shares issued at par on preferential basis.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
17 Apr - Company confirms it is not a large corporate under SEBI circular as of 31 March 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
8 Apr - Ms. Garima Garg appointed Company Secretary and Compliance Officer effective April 8, 2026; corporate office shifted.
-
Appointment of Company Secretary and Compliance Officer
8 Apr - Ms. Garima Garg appointed Company Secretary and Compliance Officer effective April 8, 2026; corporate office shifted.
-
Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
8 Apr - Ms. Garima Garg appointed Company Secretary and Compliance Officer effective April 8, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1]
a) Aquaculture Probiotic: Proteomix Protein Balanced Gel, Yuccagen Ammonia Controller, Growfast Gen Single Cell Protein, Progutgen Aquaculture Gut Probiotic, Rhodogen PS -Water Probiotic
b) Aqua Feed Supplement: Moultigen Aqua EDTA Aqua Culture, Vitagen C Aqua Culture and Zeo-Gen Multi Mineral Additive Granules from India
c) Aquaculture Water Sanitizer: Sangen- Broad Spectrum Sanitizer
d) Soil Probiotic: Genpro Wat Soil Probiotic
e) Aquaculture: Vibrio Controller In Shrimp Culture